iBio (IBIO) Current Leases (2016 - 2026)
iBio's (IBIO) quarterly Current Leases came in at $532000.0 in Q1 2026, up 11.76% year-on-year from $476000.0 in Q1 2025, and up 2.7% on a QoQ basis from $518000.0 in Q4 2025.
iBio (IBIO) Current Leases (2016 - 2026) Analysis & Trends
iBio (IBIO) has 11 years of Current Leases data on file, last reported at $532000.0 in Q1 2026.
- On a quarterly basis, Current Leases rose 11.76% year-over-year to $532000.0 in Q1 2026; TTM through Mar 2026 was $532000.0, a 11.76% increase from a year earlier, with the FY2025 full-year figure at $490000.0, up 63.88% from the prior year.
- Current Leases for Q1 2026 stood at $532000.0, up from $518000.0 in the prior quarter.
- Over the last five years, Current Leases for IBIO reached as high as $532000.0 in Q1 2026 and fell as low as $10000.0 in Q1 2022.
- Historically, Current Leases has averaged $336294.1 across 5 years, with a median of $299000.0 in 2023.
- Across the five-year window, Current Leases slumped 96.86% in 2022 and soared 2550.0% in 2023, its largest moves.
- Year by year, Current Leases stood at $259000.0 in 2022, then soared by 59.07% to $412000.0 in 2023, then slumped by 50.24% to $205000.0 in 2024, then jumped by 152.68% to $518000.0 in 2025, then rose by 2.7% to $532000.0 in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $532000.0 in Q1 2026, $518000.0 in Q4 2025, and $504000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 16.61 Mn |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | 532,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 532,000.00 |
| Dec 31, 2025 | 518,000.00 |
| Sep 30, 2025 | 504,000.00 |
| Jun 30, 2025 | 490,000.00 |
| Mar 31, 2025 | 476,000.00 |
| Dec 31, 2024 | 205,000.00 |
| Sep 30, 2024 | 490,000.00 |
| Jun 30, 2024 | 299,000.00 |
| Mar 31, 2024 | 292,000.00 |
| Dec 31, 2023 | 412,000.00 |
| Sep 30, 2023 | 299,000.00 |
| Jun 30, 2023 | 272,000.00 |
| Mar 31, 2023 | 265,000.00 |
| Dec 31, 2022 | 259,000.00 |
| Sep 30, 2022 | 303,000.00 |
| Jun 30, 2022 | 91,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Dec 31, 2021 | 45,000.00 |
| Sep 30, 2021 | 374,000.00 |
| Jun 30, 2021 | 367,000.00 |